[Acute bilateral angle closure glaucoma and choroidal effusion associated with daratumumab administration for the treatment of multiple myeloma]

J Fr Ophtalmol. 2023 May;46(5):552-553. doi: 10.1016/j.jfo.2022.07.004. Epub 2023 Apr 13.

[Article in French]

Authors

J Torbey¹, M Adler¹, S Abramowicz¹, F Willermain²

Affiliations

¹ Département d'ophtalmologie, CHU Saint-Pierre et Brugmann, université libre de Bruxelles, Bruxelles, Belgique.
² Département d'ophtalmologie, CHU Saint-Pierre et Brugmann, université libre de Bruxelles, Bruxelles, Belgique. Electronic address: Francois.Willermain@ulb.be.

PMID: 37061383
DOI: 10.1016/j.jfo.2022.07.004

No abstract available

MeSH terms

Antibodies, Monoclonal
Choroidal Effusions*
Glaucoma, Angle-Closure* / chemically induced
Glaucoma, Angle-Closure* / drug therapy
Humans
Intraocular Pressure
Multiple Myeloma* / complications
Multiple Myeloma* / drug therapy

Substances

daratumumab
Antibodies, Monoclonal